Filter
8608
Filtered Results: 8608
Text search:
Drugs
Featured
Recommendations
706
New Publications
2190
Language
Document type
No document type
5159
Studies & Reports
1217
Guidelines
1043
Manuals
355
Strategic & Response Plan
236
Fact sheets
223
Training Material
132
Situation Updates
76
Infographics
59
Resource Platforms
42
Brochures
35
Online Courses
16
Videos
11
Dashboards/Maps
2
App
2
Countries / Regions
India
488
Global
271
Kenya
250
South Africa
195
Ethiopia
179
Nepal
172
Uganda
168
Western and Central Europe
165
Nigeria
159
Sierra Leone
151
Liberia
125
Zambia
124
Tanzania
122
Malawi
121
Latin America and the Carribbean
115
Rwanda
112
Bangladesh
110
Africa
107
Ghana
106
Ukraine
106
Myanmar / Burma
101
Eastern Europe
87
Indonesia
74
Philippines
71
Namibia
71
Russia
69
Zimbabwe
63
Congo, Democratic Republic of
62
Senegal
52
Asia
52
South–East Asia Region
50
Syria
49
Cambodia
49
Germany
47
Lesotho
47
Mozambique
45
Burkina Faso
43
Brazil
41
Botswana
39
Haiti
38
South Sudan
38
Colombia
35
West and Central Africa
34
Venezuela
33
East and Southern Africa
32
Eswatini/ Swaziland
31
Middle East and North Africa
30
Cameroon
24
Guinea
23
Chile
22
Paraguay
22
Tajikistan
22
Argentina
20
Eastern Europe and Central Asia
20
Benin
19
Peru
19
USA
18
Yemen
17
Afghanistan
16
Sudan
16
Albania
16
Pakistan
15
Moldova
15
Vietnam
15
Bolivia
14
Madagascar
14
Central African Republic
12
Georgia
12
Somalia
11
Lebanon
11
Thailand
11
China
11
Western Pacific Region
11
Armenia
11
North Macedonia
10
Laos
10
Ecuador
9
Mali
8
Mexico
8
Southern Africa
8
Jordan
7
El Salvador
7
Angola
7
Sri Lanka
7
United Kingdom
7
Iraq
6
Libya
6
Palestine
6
North America
6
Guinea-Bissau
5
Turkey
5
Papua New Guinea
5
Serbia
5
Bhutan
5
Romania
5
Spain
5
Côte d’Ivoire / Ivory Coast
4
Saudi Arabia
4
Niger
4
Egypt
4
Burundi
4
Fiji
4
Poland
4
Estonia
4
Iran
4
Uzbekistan
4
Kyrgyzstan
4
Jamaica
4
Morocco
3
Chad
3
Switzerland
3
Hungary
3
Greece
3
Timor Leste/ East Timor
3
Kazakhstan
3
Uruguay
3
Belarus
3
Gambia
2
Ireland
2
Singapore
2
Honduras
2
Djibouti
2
Mongolia
2
Canada
2
Qatar
2
Lithuania
2
Gabon
2
Turkmenistan
2
Belgium
2
France
2
Mauritius
2
Tunisia
2
Portugal
2
Malaysia
1
Austria
1
Guatemala
1
Nicaragua
1
Solomon Islands
1
North Korea
1
Italy
1
Congo-Brazzaville
1
Bulgaria
1
Australia
1
Japan
1
Denmark
1
Maldives
1
Norway
1
Azerbaijan
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
3364
Clinical Guidelines
732
Public Health
390
Women & Child Health
345
Key Resources
187
Capacity Building
142
Pharmacy & Technologies
92
Annual Report MEDBOX
2
Toolboxes
HIV
916
Mental Health
873
TB
754
COVID-19
499
AMR
363
NTDs
276
Pharmacy
270
NCDs
202
Caregiver
196
Ebola
167
Rapid Response
149
Refugee
145
Conflict
128
Planetary Health
121
Disability
119
Global Health Education
86
Health Financing Toolbox
61
Natural Hazards
56
Zika
37
Cholera
34
Polio
28
Specific Hazards
26
Social Ethics
24
South Sudan
2
Health Financing
1
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
Antimicrobial agents like antibiotics are essential to treat some human and animal diseases. Microbes, such as bacteria, can develop resistance to antimicrobials meaning that a drug such as an antibiotic is no longer effective in treating the infect...
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, and reduce...
The pamphlet "ADHD Medications" provides an overview of medications commonly used to treat ADHD, such as Adderall, Vyvanse, and Ritalin. It explains that these medications do not enhance intelligence and affect individuals differently based on dosage and medical history. Potential dangers of misuse ...
Interactive Graphic.This interactive graphic covering our current knowledge of the Ebola virus and the history of disease outbreaks has now been updated with information on convalescent therapies and on drug and vaccine developmen
Open Guidelines is brought to you on behalf of the paediatrics department of Queen Elizabeth
Central Hospital in Blantyre, Malawi. Our aim is to improve access to clinical guidelines for our
health care professionals.
Open guidelines has all the latest QECH clinical protocols and essential ... information. All
content can be downloaded and afterwards be accessed at any time. The app has a search function.
Total data volume for download is 15 MB. Also on the same app one can access COIN, an excellent neonatal and
infant training course.
This job aid provides information for laboratorians about how to receive, process, and store dried blood spot specimens collected for early infant diagnosis, viral load, or drug resistance testing.
Substance abuse, is a dangerous relapsing brain disease requiring intensive treatment in a professional setting. Someone who is suffering from substance abuse will have cravings and compulsive drug use that persists even in the face of negative cons...
Antimicrobial resistance represents a big threat to public health. The Centers for Disease Control and Prevention (CDC) estimate that every year two million Americans are infected with a (multi-)drug resistant bacterium, resulting in 23,000 deaths. ...
This course will provide you with the knowledge and skills needed to implement WHO-recommended TB tests and algorithms. It includes the latest recommendations for novel tests for TB diagnosis and detection of drug resistance, as well as the most rec...
Lymphatic filariasis is a neglected tropical disease that can cause permanent disability through disruption of the lymphatic system. This disease is caused by parasitic filarial worms that are transmitted by mosquitos. Mass drug administration (MDA)...
To eliminate lymphatic filariasis (LF) by 2020, the World Health Organization (WHO) has launched a campaign against the disease. Since the launch in 2000, significant progress has been made to achieve this ambitious goal. In this article we review the progress and status of the LF programme in Afric...
The control and elimination of schistosomiasis have over the last two decades involved several strategies, with the current strategy by the World Health Organization (WHO) focusing mainly on treatment with praziquantel during mass drug administratio...
Lymphatic filariasis (LF) is an avoidable, debilitating, disfiguring disease caused by infection with the filarial parasites Wuchereria bancrofti, Brugia malayi and B. timori. Globally, 51.4 million people are
estimated to be infected. Lymphoedema and hydrocoele are the visible, chronic clinical co...
Since the launch of the Global Programme to Eliminate Lymphatic Filariasis (GPELF) in 2000, more than 910 million people have received preventive chemotherapy for lymphatic filariasis (LF) and many thousands have received care for chronic manifestations of the disease. To achieve this, millions of c...
Schistosomiasis and soil-transmitted helminths (STH) infections are major public health problems. We aimed to study the 6-mo impact of mass drug administration with praziquantel and albendazole on urinary schistosomiasis and STH.We examined children...
This document outlines the concept and content of the WHO people-centred approach to addressing antimicrobial resistance (AMR) in the human health sector. The proposed approach recognizes and aims to address the challenges and health system barriers people face when accessing health services to prev...
The pharmacological treatment of heart failure has evolved over the last three decades since the demonstration of the effect of angiotensinconverting enzyme inhibitors on major cardiovascular events in patients with heart failure with reduced ejection fraction. Composite analysis of heart failure wi...
Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021–2030 (“the road map”) sets explicit targets for the elimination of onchocerciasis by 2030, including eliminating the need for mass drug...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
